New York
CNS trials open to children and teens in New York
27 CNS studies open to children and teens are recruiting participants at sites in 14 cities across New York as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New York city with a recruiting study
By research area: Depression (9), Migraine (9), ADHD (4), Schizophrenia (3), Epilepsy (2).
New York (11), Amherst (6), Commack (3), Staten Island (3), Brooklyn (2), The Bronx (2), Buffalo (1), Glen Oaks (1), Great Neck (1), Lake Success (1), Port Jefferson Station (1), Rochester (1), Stony Brook (1), Syracuse (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
ADHD: recently updated in New York
Basic details from each study's public record (the 12 most recently updated of 27). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Staten Island
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Staten Island
- Registry record
- NCT07717892 · updated
AWARE: Management of ADHD in Autism Spectrum Disorder
- Phase 4
- Ages 4 to 17
- All sexes
- Sponsor
- Daniel Coury
- Recruiting in
- Rochester
- Registry record
- NCT05916339 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in New York on ClinicalTrials.gov.
Depression: recently updated in New York
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- No phase
- Ages 12 to 22
- All sexes
- Sponsor
- Michigan State University
- Recruiting in
- The Bronx
- Registry record
- NCT06232304 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- New York
- Registry record
- NCT06372964 · updated
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Observational
- From 18 months, up to 11 years
- All sexes
- Sponsor
- State University of New York at Buffalo
- Recruiting in
- Buffalo
- Registry record
- NCT07048574 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in New York on ClinicalTrials.gov.
Migraine: recently updated in New York
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Amherst · Commack · Great Neck · and 2 more U.S. locations
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Amherst · Commack · New York
- Registry record
- NCT04743141 · updated
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- The Bronx
- Registry record
- NCT05156398 · updated
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Recruiting in
- Commack
- Registry record
- NCT05164172 · updated
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Amherst
- Registry record
- NCT06810505 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in New York on ClinicalTrials.gov.
Schizophrenia: recently updated in New York
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Phase 3
- Ages 5 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Recruiting in
- New York · Staten Island
- Registry record
- NCT06229210 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in New York on ClinicalTrials.gov.
Ask about studies in New York
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.
CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections